Health In Tech Signs $7M Private Placement Agreement
Health In Tech announced that it has entered into a securities purchase agreement for a private investment in public equity financing that is expected to result in gross proceeds of approximately $7M before deducting placement agent fees and offering expenses. The PIPE is expected to close on or about March 27, subject to the satisfaction of customary closing conditions. Pursuant to the terms of the securities purchase agreement, at the closing of the PIPE, Health In Tech will issue an aggregate of 5.6M shares of Class A common stock at a price of $1.25 per share. Craig-Hallum Capital Group acted as the sole placement agent for the PIPE.
Trade with 70% Backtested Accuracy
Analyst Views on HIT
About HIT
About the author

- Financing Amount: Health In Tech has successfully closed a private investment in public equity (PIPE) financing, raising approximately $7 million by issuing 5,600,000 shares at $1.25 each, which will provide essential funding to support the next phase of platform development.
- Support for Strategic Growth: CEO Tim Johnson stated that the additional capital will be allocated to key technology initiatives, enabling the company to launch new product capabilities actively requested by clients, thereby enhancing customer engagement and supporting sustainable revenue growth.
- Increased Market Visibility: CFO Julia Qian highlighted that the transaction introduces new long-term institutional investors, which is expected to enhance the company's market visibility and support a broader capital markets strategy, thereby strengthening its competitive position in the industry.
- Compliance Statement: The securities are being offered under Section 4(a)(2) of the Securities Act of 1933 and have not been registered in the U.S., requiring investors to be aware of registration requirements and legal restrictions to ensure compliance.
- Financing Amount: Health In Tech has successfully closed a private investment in public equity (PIPE) financing, raising approximately $7 million by issuing 5,600,000 shares at $1.25 each, which will provide essential funding for the company's technology development.
- Use of Proceeds: The company intends to allocate the net proceeds towards expanding sales distribution, advancing technology development, and supporting new product initiatives, thereby enhancing market competitiveness and addressing client demands to drive sustainable revenue growth.
- Investor Base Expansion: This transaction introduces new long-term institutional investors, which is expected to enhance the company's market visibility and support a broader capital markets strategy, thereby increasing financial flexibility.
- Strategic Development: CEO Tim Johnson stated that this financing will accelerate the next phase of platform development, further deepen customer engagement, and support the company's long-term growth strategy.
- Financing Amount: Health In Tech successfully closed a PIPE financing of approximately $7 million, issuing 5,600,000 shares of common stock at $1.25 per share, which will provide essential funding for the company's platform development and enhance its competitive position in the market.
- Use of Proceeds: The company intends to allocate the proceeds towards expanding sales distribution, advancing technology development, and supporting new product initiatives, which will help deepen customer engagement and drive sustainable revenue growth.
- Investor Base Enhancement: This transaction introduces new long-term institutional investors to the shareholder base, which is expected to enhance market visibility and support the company's broader capital markets strategy while providing the flexibility to continue investing in technology and growth initiatives.
- Compliance Statement: The financing is conducted under Section 4(a)(2) of the Securities Act of 1933, and the securities have not been registered in the U.S., indicating that a resale registration statement may be required in the future to comply with securities laws.

Health in Tech: The health technology sector is experiencing significant financial activity, with gross proceeds from a recent PIPE expected to reach approximately $7 million.
PIPE Financing: The anticipated PIPE (Private Investment in Public Equity) filing indicates a strong interest in health tech investments, reflecting confidence in the sector's growth potential.

- Health Tech Company Agreement: A health technology company has entered into an agreement for the issuance of 5,600,000 common shares.
- SEC Filing: The agreement has been filed with the Securities and Exchange Commission (SEC).








